A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
about
Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β ProductionAndrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.Non-alcoholic fatty liver and the gut microbiota.Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.Gold-quercetin nanoparticles prevent metabolic endotoxemia-induced kidney injury by regulating TLR4/NF-κB signaling and Nrf2 pathway in high fat diet fed mice.Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity.Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease.Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice.Phloxine O, a Cosmetic Colorant, Suppresses the Expression of Thymic Stromal Lymphopoietin and Acute Dermatitis Symptoms in Mice.Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.Association of Inflammatory Responses and ECM Disorganization with HMGB1 Upregulation and NLRP3 Inflammasome Activation in the Injured Rotator Cuff Tendon.Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
P2860
Q28072287-99348394-3286-4575-B08B-56C20C2750E1Q33799384-FA447631-28AE-483F-B9D8-179991FC9ED1Q36405748-7951C133-DEEE-4DBD-9806-18180305E8E6Q37215934-2DF57675-EC3B-4D22-9CAD-F8361F9A8270Q37488147-1F9BF6E4-18F4-438F-9FFD-5D092CE563C0Q37573794-0E6B1635-1F18-484D-A5FA-FA8DF48D5E71Q40192795-8FD110CC-12E0-43E3-91F1-718569A22075Q42172913-30464D8B-60D4-436B-80F1-F3454CDDD8ACQ42281562-F9F005D2-EDD0-4987-8490-B9C318C489ADQ47556931-3FD6CED5-A56A-4868-A665-D0BE102F6FCDQ48534533-9E6D06A6-386F-4F20-B495-E8FB9C4F5CC9Q50052148-E2CC6DFE-6050-40BD-A8C9-F4EF9DFD7074Q50136135-94DA760C-95AD-4A56-9087-568F77390FFAQ52649427-F0E1CB7C-2519-4E8A-87BA-38A9C7C74009Q52659646-EC06F4F0-A0F9-40E3-B9D0-1485593EB38DQ55347993-07BB0E15-4BA6-44AE-987C-1363A30CD5F9Q55447541-4ACF5B08-C085-4C14-87BD-040C90C1A75BQ58784853-38196AC0-2868-4564-B58A-10544D7CC010
P2860
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A pharmacological inhibitor of ...... odel induced by high fat diet.
@en
type
label
A pharmacological inhibitor of ...... odel induced by high fat diet.
@en
prefLabel
A pharmacological inhibitor of ...... odel induced by high fat diet.
@en
P2093
P2860
P356
P1433
P1476
A pharmacological inhibitor of ...... odel induced by high fat diet.
@en
P2093
Gabsik Yang
Hye Eun Lee
Joo Young Lee
P2860
P2888
P356
10.1038/SREP24399
P407
P577
2016-04-14T00:00:00Z